liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Comments: The treatment of bacterial vaginosis in pregnancy with clindamycin to reduce the risk of infection-related preterm birth: a response to the Danish Society of Obstetrics and Gynecology guideline groups clinical recommendations (
UCL, England; University of Southern Denmark, Denmark.
University of Western Australia, Australia.
Linköping University, Department of Clinical and Experimental Medicine, Division of Children's and Women's health. Linköping University, Faculty of Medicine and Health Sciences. Skaraborg Hosp, Dept Obstet and Gynecol, Skovde, Sweden.
University of Southern Denmark, Denmark; Odense University Hospital, Denmark.
2017 (English)In: Acta Obstetricia et Gynecologica Scandinavica, ISSN 0001-6349, E-ISSN 1600-0412, Vol. 96, no 2, p. 139-143Article in journal, Editorial material (Other academic) Published
Abstract [en]

Preterm birth is the major cause of perinatal mortality and morbidity worldwide. Infection/inflammation is responsible for a significant percentage of preterm birth, particularly at early gestations. A recent clinical recommendation by a guidelines group of the Danish Society of Obstetrics and Gynecology advised against the use of clindamycin for the treatment of bacterial vaginosis in pregnancy to reduce the risk of spontaneous preterm birth based on lack of evidence of efficacy. We believe that the evidence for the use of clindamycin for this indication is robust and that this recommendation was reached erroneously on the basis of flawed inclusion criteria: the inclusion of an unpublished study with poorly diagnosed bacterial vaginosis and the exclusion of an important pivotal study on the use of clindamycin in early pregnancy for the prevention of preterm birth. Had these errors been corrected, the conclusions would have been different.

Place, publisher, year, edition, pages
WILEY-BLACKWELL , 2017. Vol. 96, no 2, p. 139-143
Keywords [en]
Antibiotics; bacterial vaginosis; clindamycin; infection; preterm birth; preterm labor; prevention
National Category
Gynaecology, Obstetrics and Reproductive Medicine
Identifiers
URN: urn:nbn:se:liu:diva-135718DOI: 10.1111/aogs.13065ISI: 000393615900002PubMedID: 27874978OAI: oai:DiVA.org:liu-135718DiVA, id: diva2:1082768
Available from: 2017-03-17 Created: 2017-03-17 Last updated: 2025-02-11

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Larsson, Per-Göran

Search in DiVA

By author/editor
Larsson, Per-Göran
By organisation
Division of Children's and Women's healthFaculty of Medicine and Health Sciences
In the same journal
Acta Obstetricia et Gynecologica Scandinavica
Gynaecology, Obstetrics and Reproductive Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 129 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf